Familial TTR amyloid polyneuropathy (FAP TTR): differential diagnosis
Evidence-based neurology checklist on familial ttr amyloid polyneuropathy (fap ttr): differential diagnosis: CIDP This is the commonest misdiagnosis of FAP FAP may fulfil the criteria for CIDP Marked axonal loss may differentiate FAP from CIDP Consider FAP if CIDP is not responding to treatment…
CIDP
- This is the commonest misdiagnosis of FAP
- FAP may fulfil the criteria for CIDP
- Marked axonal loss may differentiate FAP from CIDP
- Consider FAP if CIDP is not responding to treatment
Other FAP types
Other hereditary neuropathies
Other neuropathies
Other differentials
Acronym
References
- Adams D, Suhr OB, Hund E, et al; European Network for TTR-FAP (ATTReuNET). First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy. Curr Opin Neurol 2016; 29(Suppl 1):S14-S26.
- Lozeron P, Mariani LL, Dodet P, et al. Transthyretin amyloid polyneuropathies mimicking a demyelinating polyneuropathy. Neurology 2018; 91:e143-e152.
- Plante-Bordeneuve V, Ferreira A, Lalu T, et al. Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP). Neurology 2007; 69:693-698.
- Mathis S, Magy L, Diallo L, Boukhris S, Vallat JM. Amyloid neuropathy mimicking chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 2012; 45:26-31.
